If you or someone close to you has been diagnosed with early-stage breast cancer, our two-part webinar series on understanding the risk of breast cancer recurrence, available therapies that can help reduce the risk of recurrence, and how to manage side effects may be helpful to you.
Part I: Understanding risk of recurrence: Tests and treatments
In this session, Virginia Borges MD, MMSc discussed:
- Different levels of breast cancer recurrence risk
- Unique needs of individuals living with a high risk of recurrence
- Tests used to assess risk, including the latest in testing innovations
- Treatments that can help reduce the risk of recurrence
Dr. Borges shared tips on lifestyle modifications to support health and wellbeing after a breast cancer diagnosis, and how to talk to your doctor about your individual risk of recurrence.
Virginia F. Borges, MD, MMSc
Deputy Head, Division of Medical Oncology Director, Breast Cancer Research Program & Young Women’s Breast Cancer Translational Program at the University of Colorado Anschutz Medical Campus
Virginia F. Borges, MD, MMSc, founded and directs the Young Women’s Breast Cancer Clinic at the University of Colorado Comprehensive Cancer Center. The YWBCC of Colorado covers the unique issues of young women at diagnosis, through treatment, and beyond. She is on the Medical Advisory Board for Living Beyond Breast Cancer.Read more
Thank you to our Part I sponsors
Part II: Managing treatment side effects of anti-estrogen therapies
Treatments that reduce the risk of breast cancer recurrence can also cause side effects. Some common side effects can include menopausal symptoms such as hot flashes, bone loss, joint pain, and sexual side effects. There can also be concerns about heart health.
In this session, Evelyn Robles-Rodriguez DNP, APN, AOCN discussed side effects caused by anti-estrogen therapies such as tamoxifen, aromatase inhibitors, and ovarian suppression, plus ways to manage them.
She was joined by a panel of people who’ve taken some of these treatments, and they shared their personal experiences with managing side effects.
Evelyn Robles-Rodriguez DNP, APN, AOCN
Director of Outreach, Prevention, and Survivorship, MD Anderson Cancer Center at Cooper
Evelyn Robles-Rodriguez, DNP, APN, AOCN serves as the director for outreach, prevention, and survivorship. Her research interests are in breast cancer, solid tumors, cancer screening and prevention, women's health, and cancer survivorship.
She is bilingual in English and Spanish and is committed to the cancer education of the lay and professional community. She is on the Medical Advisory Board for Living Beyond Breast Cancer.Read more
Tandria, known as Tan, is a single mother of twins who relocated to Georgia just before the pandemic's onset. In the fall of 2020 she was diagnosed with stage IIB DCIS breast cancer and embarked on a comprehensive treatment journey. As she navigates her way through survivorship, Tan is currently undergoing hormone therapy, which includes Letrozole, Lupron injections, and Verzenio. Tan serves as an ambassador for For the Breast of Us and as an ANGEL Advocate for Tigerlily.Read more
Founder and CEO, deClarity
Diane Heditsian, a four-time breast cancer survivor, integrates her personal journey with an unwavering passion to enhance healthcare. Diane often addresses physician, researcher, and patient audiences nationally and internationally on breast cancer topics. She developed and presented An Advocate’s Prescription for Survivorship Care at ASCO’s inaugural Cancer Survivorship Symposium. For two decades, she has been serving as a breast cancer peer counselor including with Living Beyond Breast Cancer and UCSF Health’s Breast Care Center. She was awarded a Fulbright Specialist designation in Cancer Advocacy to help develop cancer advocacy programs around the world.Read more
Alicia lives in Oceanside, California, with her husband, two boys, two dogs, and a tortoise. She is a nurse case manager in a breast health clinic. Alicia was diagnosed with breast cancer in March 2021, after learning that she had a BRCA mutation. Alicia went through chemotherapy, a bilateral mastectomy with sentinel lymph node biopsy, ovarian suppression, a PARP inhibitor, radiation, oophorectomy, and DIEP flap breast reconstruction surgery. She is in her second year of endocrine therapy. She is a member of 2022 LBBC's Young Advocate program.Read more
Thank you to our Part II sponsors
Sign up to receive emotional support, medical insight, personal stories, and more, delivered to your inbox weekly.